Brokerages Set Synopsys, Inc. (NASDAQ:SNPS) Price Target at $562.13

Synopsys, Inc. (NASDAQ:SNPS) has earned an average recommendation of “Moderate Buy” from the eighteen brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and eleven have given a buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $562.1333.

Several analysts have commented on SNPS shares. Piper Sandler decreased their price target on shares of Synopsys from $630.00 to $602.00 and set an “overweight” rating on the stock in a research note on Thursday, December 11th. BNP Paribas initiated coverage on Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target for the company. JPMorgan Chase & Co. raised their price target on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, Robert W. Baird reiterated a “neutral” rating and set a $535.00 target price (down from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.62% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Symphony Financial Ltd. Co. lifted its holdings in Synopsys by 4,780.9% in the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after purchasing an additional 39,395 shares in the last quarter. HBW Advisory Services LLC lifted its stake in shares of Synopsys by 494.9% in the second quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock worth $1,851,000 after buying an additional 3,004 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Synopsys by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after acquiring an additional 4,815 shares during the last quarter. Westbourne Investments Inc. purchased a new stake in Synopsys during the 2nd quarter valued at about $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Synopsys by 1.7% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock valued at $91,660,000 after acquiring an additional 2,991 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Synopsys Stock Up 0.3%

Shares of SNPS opened at $477.14 on Wednesday. The business’s 50 day moving average is $437.58 and its 200 day moving average is $503.62. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys has a 12-month low of $365.74 and a 12-month high of $651.73. The company has a market capitalization of $91.29 billion, a PE ratio of 59.72, a price-to-earnings-growth ratio of 3.97 and a beta of 1.16.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period last year, the firm posted $3.40 EPS. The company’s revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts expect that Synopsys will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.